The significance of personalized monitoring of the hemostatic potential in a patient with combined thrombophilia concurrent with thrombocytopathy in enhancing the efficiency of in vitro fertilization

Tyutrin I.I., Klimenkova V.F., Slizevich D.S., Shitikova O.G., Borzov E.A.

1) Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia; 2) I.D. Evtushenko Regional Perinatal Center, Tomsk, Russia; 3) Tomsk National Research Polytechnical University, Tomsk, Russia
Background. The hemostatic and fibrinolytic systems play a key role in the systemic circulatory adaptation of the woman’s body to pregnancy and childbirth. In the presence of acquired or genetic hemostatic abnormalities (thrombophilia, thrombocytopathy, and coagulopathy), the physiological activation of coagulation processes and systemic inflammation during pregnancy can lead to decompensation in the equilibrium of the hemostatic potential (HP) and thereby provoke obstetric complications.
Case report. The paper demonstrates a clinical observation of a female patient with concomitant hemostasiological disorders (thrombocytopathy, a carrier of heterozygous thrombophilia polymorphisms: ITGB3, ITGA2, PAI-1, and MTHFR). She has a history of repeated ineffective ART program attempts. Spontaneous abortion occurred during the early stages of hemorrhagic syndrome when low-molecular-weight heparin was used. An approach to managing this patient was proposed. The principle was the personalized monitoring of the hemostatic system by low-frequency thromboelastography. Owing to the latter, it was possible to have a real-time comprehensive and informative assessment of the parameters of hemocoagulation and fibrinolysis in whole blood. The detected HP disorders was corrected with the targeted therapy: Etamsilat (Lugansk Chemopharmaceutical Plant, Ukraine) was used to correct hypocoagulation at the first stage of fibrinogenesis; Tranexam (STADA, Russia) to suppress enhanced fibrinolytic activity; Vessel Due F (sulodexide) (Alfasigma S.p.A., Italy) to correct a hypercoagulable state, which should not have been routinely done in this patient, as thought by the authors. Monitoring the efficiency of the 2P+2D therapy could prolong pregnancy to full term, resulting in the birth of a healthy baby.
Conclusion. Thus, the personalized approach to managing the patient with concomitant hemostasiological disorders and IVF contribute to the increased take-home-baby rate.

Keywords

hemostasis and fibrinolysis
pregnancy
thromboelastography
thrombophilia
thrombocytopathy
Vessel Due F (sulodexide)

References

  1. Квашнина Е.В., Аскеров Р.А., Маясина Е.Н. Take-home baby -критерий оценки качества технологии ЭКО, оценка группы беременных женщин. Проблемы репродукции. 2012; 18(2): 68-71. [Kvashnina E.V., Askerov R.A., Maiasina E.N. Take-home baby rate as a criteria of IVF quality. The analysis of pregnant women. Problems of reproduction. 2012; 18(2): 68-71. (in Russian)].
  2. Тютрин И.И., Удут В.В., Клименкова В.Ф. Функциональное состояние системы гемостаза беременных, по данным «глобального» теста низкочастотной пьезотромбоэластографии. Патологическая физиология и экспериментальная терапия. 2014; 58(2): 61-7. [Tyutrin I.I., Udut V.V., Klimenkova V.F. The functional status of pregnant women hemostasis according to the “global” low-frequency piezothromboelastography test. Pathological physiology and experimental therapy. 2014; 58(2): 61-7. (in Russian)].
  3. Путилова Н.В., Башмакова Н.В. Современные принципы ведения пациенток с тромбофилией с позиции доказательной медицины. Акушерство и гинекология. 2012; 6: 15-20. [Putilova N.V., Bashmakova N.V. Current principles in the management of patients with thrombophilia in the context of evidence-based medicine. Obstetrics and Gynecology. 2012; 6: 15-20. (in Russian)].
  4. Подзолкова Н.М., Колода Ю.А., Коренная В.В., Даньшина В.А., Кайибханова К.М. Наследственные и приобретенные тромбофилии: влияние на функциональное состояние эндометрия и яичников (обзор литературы). Проблемы репродукции. 2015; 21(1): 26-9. [Podzolkova N.M., Koloda Yu.A., Korennaia V.V., Dan’shina V.A., Kaĭibkhanova K.M. Inherited and acquired trombophilia: the impact on endometrial and ovarian function (a review). Problems of reproduction. 2015; 21(1): 26-9. (in Russian)].
  5. Сафиуллина С.И., Вуймо Т.А., Илизарова Н.А., Сабирова В.Л., Сигитова О.Н., Пырегов А.В. Современные возможности персонифицированной тромбопрофилактики во время проведения протокола вспомогательных репродуктивных технологий и во время беременности у женщины с высоким риском венозных тромбоэмболических осложнений. Акушерство и гинекология. 2018; 4: 144-9. https://dx.doi.org/10.18565/aig.2018.4.144-149. [Safiullina S.I. Vuimo T.A. Ilizarova N.A., Sabirova V.L., Sigitova L.N., Pyregov A.V. Current possibilities of personalized thromboprophylaxis when implementing an assisted reproductive technology protocol and during pregnancy in women at high risk for venous thromboembolism. Obstetrics and Gynecology. 2018; 4: 144-9. (in Russian)].
  6. Khalafallah A.A., Ibraheem A.R., Teo Q.Y., Albarzan A.M., Parameswaran R., Hooper E. et al. Review of management and out-comes in women with thrombophilia risk during pregnancy at a single institution. ISRN Obstet. Gynecol. 2014; 2014: 1-6. https://dx.doi.org/10.1155/2014/381826.
  7. Тютрин И.И., Удут В.В. Низкочастотная пьезотромбоэластография цельной крови: алгоритмы диагностики и коррекции гемостазиологических расстройств. Томск: Национальный исследовательский Томский государственный университет; 2016. 170с. [Tyutrin I.I., Udut V.V. Low-frequency piezothromboelastography of whole blood: algorithms for the diagnosis and correction of hemostasiological disorders. Tomsk: Publishing House of Tomsk State University; 2016. 170 p. (in Russian)].
  8. Tarabrin O., Tyutrin I., Tkachenko R., Shcherbakov S., Gavrychenko D. The correlation analysis of hemovisnoelastografy and traditional tests of blood coagulation. Br. J. Anaesth. 2012; 108(1): 56-7.
  9. Тютрин И.И., Клименкова В.Ф., Удут В.В. Новая технология оценки фармакодинамики антиагрегантов. Экcпеpиментальная и клиничеcкая фаpмакология. 2014; 77(2): 21-5. [Tyutrin I.I., Klimenkova V.F., Udut V.V. A new technology for evaluating pharmacodynamics of antiaggregants. Experimental and Clinical Pharmacology. 2014; 77(2): 21-5. (in Russian)].
  10. Каиров Г.Т., Тютрин И.И., Удут В.В., Клименкова В.Ф. Информативность «Глобальных» тестов в оценке функционального состояния системы гемостаза здоровых женщин. Тромбоз, гемостаз и реология. 2016; Приложение 3 (Тезисы 3-го Всемирного конгресса «Controversies in thrombosis and hemostasis»): 184-5. [Kairov G.T., Tyutrin I.I., Udut V.V., Klimenkova V.F. Informativeness “of global” tests in assessment of haemostasis functional state at healthy women. Thrombosis, hemostasis and rheology. 2016; S3 (67): 184-5. (in Russian)].
  11. Ящук А.Г., Масленников А.В., Фаткуллина И.Б., Рахматуллина И.Р., Берг Э.А., Берг П.А. Применение сулодексида для улучшения внутриматочной гемодинамики у пациенток с невынашиванием беременности. Акушерство и гинекология. 2019; 10: 172-9. https://dx.doi.org/ 10.18565/aig.2019.10.172-178. [Yashchuk, A.G., Maslennikov, A.V., Fatkullina, I.B., Rakhmatullina, I.R. Use of sulodexide to improve intrauterine hemodynamics in patients with miscarriage. Obstetrics and Gynecology. 2019; 10: 172-9. (in Russian)].
  12. Прегравидарная подготовка. Клинический протокол Междисциплинарной ассоциации специалистов репродуктивной медицины (МАРС). Версия 2.0 М.: Редакция журнала StatusPraesens; 2020. 128 с. [Pregravid preparation. Clinical Protocol of the Interdisciplinary Association of Reproductive Medicine Professionals (MARS). Version 2.0 [Team of authors]. Moscow: StatusPraesens magazine editorial office; 2020. 128 p. (in Russian)].
  13. Кузнецова И.В. Эндотелиальная дисфункция в контексте нарушений здоровья женщин от менархе до менопаузы. Медицинский алфавит. 2019; 4(33): 39-47. [Kuznetsova I.V. Endothelial dysfunction in context of women’s health disorders from menarche to menopause. Medical alphabet. 2019; 4(33): 39-47. (in Russian)].
  14. Jarząbek K., Gabryel B., Urbanek T. Sulodexide in the treatment of vascular disease: its therapeutic action on the endothelium. Phlebol. Rev. 2016; 24(4): 51-9. https://dx.doi.org/10.5114/pr.2016.67742.

Received 16.11.2020

Accepted 24.11.2020

About the Authors

Ivan I. Tyutrin, Dr. Med. Sci., Professor, Professor of the Department of anesthesiology, resuscitation and intensive care, Siberian State Medical University,
Ministry of Health of the Russian Federation. E-mail: ityutrinst@yandex.ru. ORCID: 0000-0001-9893-700X.
2 Moskovsky trakt str., Tomsk, 634050, Russia.
Valentina F. Klimenkova, Cand. Med. Sci., assistant of the Department of anesthesiology, resuscitation and intensive care, Siberian State Medical University,
Ministry of Health of the Russian Federation; Regional perinatal center named after I.D. Yevtushenko. Tel.: +7(3822)909-823, +7(3822)33-02-11.
E-mail: klimenkovavf@gmail.com. ORCID: 0000-0002-5506-2247. 2 Moskovsky trakt str., Tomsk, 634050, Russia; 96/1 I. Chernykh str., Tomsk, 634063, Russia.
Dmitry S. Slizevich postgraduate student, research school of chemical and biomedical technologies, National Research Tomsk Polytechnic University.
ORCID: 0000-0001-5053-1561 30 Lenin Ave., Tomsk, 634050, Russia.
Olga G. Shitikova, PhD, assistant of the Department of biochemistry and molecular biology with a course in clinical laboratory diagnostics, Siberian State Medical University, Ministry of Health of the Russian Federation. E-mail: olya.lya@mail.ru. ORCID: 0000-0002-4057-9964. Moskovsky trakt str., Tomsk, 634050, Russia.
Evgeny A. Borzov, post-graduate student of the Department of anesthesiology, resuscitation and intensive care, Siberian State Medical University, Ministry of Health of the Russian Federation; Regional perinatal center named after I.D. Yevtushenko. Tel.: +7(3822)909-823, +7(3822)33-02-11.
2 Moskovsky trakt str., Tomsk, 634050, Russia; 96/1 I. Chernykh str., Tomsk, 634063, Russia.

For citation: Tyutrin I.I., Klimenkova V.F., Slizevich D.S., Shitikova O.G., Borzov E.A. The significance of personalized monitoring of the hemostatic potential in a patient with combined thrombophilia concurrent with thrombocytopathy in enhancing the efficiency of in vitro fertilization.
Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2020; 12: 249-254 (in Russian)
https://dx.doi.org/10.18565/aig.2020.12.249-254

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.